These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37021198)

  • 21. New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons.
    Sardar P; Chatterjee S; Wu WC; Lichstein E; Ghosh J; Aikat S; Mukherjee D
    PLoS One; 2013; 8(10):e77694. PubMed ID: 24204920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation: Results from the RAFFINE registry.
    Yamashiro K; Tanaka R; Miyazaki S; Miyauchi K; Hayashi H; Nishizaki Y; Nojiri S; Suwa S; Sumiyosi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H
    J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106871. PubMed ID: 36356431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol.
    Cameron AC; Katsas G; Arnold M; Docherty K; Campbell RT; Murdoch D; McClure JD; Katan M; Lip GYH; Abdul-Rahim AH; Dawson J
    Cerebrovasc Dis; 2023; 52(2):123-129. PubMed ID: 36037797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
    Arch Intern Med; 1994 Jul; 154(13):1449-57. PubMed ID: 8018000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
    Best JG; Arram L; Ahmed N; Balogun M; Bennett K; Bordea E; Campos MG; Caverly E; Chau M; Cohen H; Dehbi HM; Doré CJ; Engelter ST; Fenner R; Freemantle N; Hunter R; James M; Lip GY; Murray ML; Norrving B; Sprigg N; Veltkamp R; Zaczyk I; Werring DJ;
    Int J Stroke; 2022 Jun; 17(5):583-589. PubMed ID: 35018878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001927. PubMed ID: 16034869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.
    Kimura S; Toyoda K; Yoshimura S; Minematsu K; Yasaka M; Paciaroni M; Werring DJ; Yamagami H; Nagao T; Yoshimura S; Polymeris A; Zietz A; Engelter ST; Kallmünzer B; Cappellari M; Chiba T; Yoshimoto T; Shiozawa M; Kitazono T; Koga M;
    Stroke; 2022 May; 53(5):1540-1549. PubMed ID: 35105180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Outpatient Cardiac Rhythm Monitoring in Cryptogenic Stroke: A Systematic Review and Meta-Analysis.
    Afzal MR; Gunda S; Waheed S; Sehar N; Maybrook RJ; Dawn B; Lakkireddy D
    Pacing Clin Electrophysiol; 2015 Oct; 38(10):1236-45. PubMed ID: 26172621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views.
    Sposato LA; Chaturvedi S; Hsieh CY; Morillo CA; Kamel H
    Stroke; 2022 Mar; 53(3):e94-e103. PubMed ID: 34986652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial.
    Ha ACT; Verma S; Mazer CD; Quan A; Yanagawa B; Latter DA; Yau TM; Jacques F; Brown CD; Singal RK; Yamashita MH; Saha T; Teoh KH; Lam BK; Deyell MW; Wilson M; Hibino M; Cheung CC; Kosmopoulos A; Garg V; Brodutch S; Teoh H; Zuo F; Thorpe KE; Jüni P; Bhatt DL; Verma A;
    JAMA Netw Open; 2021 Aug; 4(8):e2121867. PubMed ID: 34448866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials.
    Brockmeyer M; Lin Y; Parco C; Karathanos A; Krieger T; Schulze V; Heinen Y; Bejinariu A; Müller P; Makimoto H; Kelm M; Wolff G
    Acta Cardiol; 2021 May; 76(3):288-295. PubMed ID: 32056498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke.
    Singer DE; Ziegler PD; Koehler JL; Sarkar S; Passman RS
    JAMA Cardiol; 2021 Dec; 6(12):1364-1369. PubMed ID: 34586356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insertable cardiac monitoring devices versus external cardiac monitoring for detecting atrial fibrillation and preventing the recurrence of stroke: A systematic review and meta-analysis.
    Al Qurashi AA; Rasheed F; Siddiqi AR; Abdullah M; Mumtaz M; Khan T; Mallick AH; Jabeen S; Ahmed IE; Ochani RK
    J Electrocardiol; 2023; 77():29-36. PubMed ID: 36577318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
    Van Der Meersch H; De Bacquer D; De Vriese AS
    Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.